• 1
    Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V, et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996; 274: 13791383.
  • 2
    Petersen BE, Grossbard B, Hatch H, Pi L, Deng J, Scott EW. Mouse A6-positive hepatic oval cells also express several hematopoietic stem cell markers. HEPATOLOGY 2003; 37: 632640.
  • 3
    Yamada Y, Kirillova I, Peschon JJ, Fausto N. Initiation of liver growth by tumor necrosis factor: deficient liver regeneraton in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci U S A 1997; 94: 14411446.
  • 4
    Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 2003; 374: 120.
  • 5
    Croker BA, Krebs DL, Zhang JG, Wormald S, Willson TA, Stanley EG, et al. SOCS3 negatively regulates IL-6 signalling in vivo. Nat Immunol 2003; 4: 540545.
  • 6
    Campbell JS, Prichard L, Schaper F, Schmitz J, Stephenson-Famy A, Rosenfeld ME, et al. Expression of suppressors of cytokine signalling during liver regeneration. J Clin Invest 2001; 107: 12851292.
  • 7
    Sun R, Jaruga B, Kulkarni S, Sun H, Gao B. IL-6 modulates hepatocyte proliferation via induction of HGF/p21cip1: Regulation by SOCS-3. Biochem Biophys Res Commun 2005; 338: 19431949.
  • 8
    Tebbutt NC, Giraud AS, Inglese M, Jenkins B, Waring P, Clay FJ, et al. Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice. Nat Med 2002; 8: 10891097.
  • 9
    Jenkins BJ, Roberts AW, Najdovska M, Grail D, Ernst M. The threshold of gp130-dependent STAT3 signalling is critical for normal regulation of hematopoiesis: the threshold of gp130-dependent STAT3 signalling is critical for normal regulation of hematopoiesis. Blood 2005; 105: 35123520.
  • 10
    Ernst M, Inglese M, Waring P, Campbell IK, Bao S, Clay FJ, et al. Defective gp130-mediated signal transducer and activator of transcription (STAT) signalling results in degenerative joint disease, gastrointestinal ulceration, and failure of uterine implantation. J Exp Med 2001; 194: 189203.
  • 11
    Fischer M, Goldschmitt J, Peschel C, Kallen KJ, Brakenhoff JPJ, Wollmer A, et al. A designer cytokine with high activity on human hematopoietic progenitor cells. Nat Biotechnol 1997; 15: 142145.
  • 12
    Peters M, Blinn G, Solem F, Fischer M, Meyer zum Buschenfelde K-H, Rose-John S. In vivo and in vitro activities of the gp130-stimulating designer cytokine hyper IL-6. J Immunol 1998; 161: 35753581.
  • 13
    Dumble ML, Croager EJ, Yeoh GC, Quail EA. Generation and characterisation of p53 null transformed hepatic progenitor cells: oval cells give rise to hepatocellular carcinoma. Carcinogenesis 2002; 23: 435445.
  • 14
    Matthews VB, Klinken E, Yeoh GC. Direct effects of interleukin-6 on liver progenitor oval cells in culture. Wound Repair Regen 2004; 12: 650656.
  • 15
    Matthews VB, Knight B, Tirnitz-Parker JE, Boon J, Olynyk JK, Yeoh G. Oncostatin M induces an acute phase response but does not modulate the growth or maturation-status of liver progenitor (oval) cells in culture. Exp Cell Res 2005; 306: 252263.
  • 16
    Strick-Marchand H, Weiss MC. Inducible differentiation and morphogenesis of bipotential liver cell lines from wild-type mouse embryos. HEPATOLOGY 2002; 36: 794804.
  • 17
    Knight B, Yeoh GCT, Husk KL, Ly T, Abraham LJ, Yu C, et al. Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type I knockout mice. J Exp Med 2000; 192: 18091818.
  • 18
    Akhurst B, Matthews V, Husk K, Smyth MJ, Abraham LJ, Yeoh GC. Differential lymphotoxin-beta and interferon gamma signaling during mouse liver regeneration induced by chronic and acute injury. HEPATOLOGY 2005; 41: 327335.
  • 19
    Knight B, Matthews VB, Akhurst B, Croager EJ, Klinken E, Abraham LJ, et al. Liver inflammation and cytokine production, but not acute phase protein synthesis, accompany the adult liver progenitor (oval) cell response to chronic liver injury. Immunol Cell Biol 2005; 83: 364374.
    Direct Link:
  • 20
    Tam SP, Lau P, Djiane J, Hilton DJ, Waters MJ. Tissue-specific induction of SOCS gene expression by PRL. Endocrinology 2001; 142: 50155026.
  • 21
    Vuillermoz B, Khoruzhenko A, D'Onofrio MF, Ramont L, Venteo L, Perreau C, et al. The small leucine-rich proteoglycan lumican inhibits melanoma progression. Exp Cell Res 2004; 296: 294306.
  • 22
    Peeters SD, Hovenga S, Rosati S, Vellenga E. Bcl-xL expression in multiple myeloma. Med Oncol 2005; 22: 183190.
  • 23
    Park S, Kim D, Kaneko S, Szewczyk KM, Nicosia SV, Yu H, et al. Molecular cloning and characterization of the human AKT1 promoter uncovers its upregulation by the Src/Stat3 pathway. J Biol Chem 2005; 280: 3893238941.
  • 24
    Jenkins BJ, Grail D, Nheu T, Najdovska M. Wang B, Waring P, et al. Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-β signaling. Nat Med 2005; 11: 845852.
  • 25
    Niwa Y, Kanda H, Shikauchi Y, Saiura A, Matsubara K, Kitagawa T, et al. Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signaling in human hepatocellular carcinoma. Oncogene 2005; 24: 64066417.
  • 26
    Haan S, Keller JF, Behrmann I, Heinrich PC, Haan C. Multiple reasons for an inefficient STAT-1 response upon IL-6-type cytokine stimulation. Cell Signal 2005; 17: 15421550.
  • 27
    Alonzi T, Maritano D, Gorgoni B, Rizzuto G, Libert C, Poli V. Essential role of STAT-3 in the control of the acute phase response as revealed by inducible gene activation in the liver. Mol Cell Biol 2001; 21: 16211632.
  • 28
    Sanchez A, Factor VM, Schroeder IS, Nagy P, Thorgeirsson SS. Activation of NF-κB and STAT3 in rat oval cells during acetylaminofluorene/partial hepatectomy-induced liver regeneration. HEPATOLOGY 2004; 39: 376385.
  • 29
    Kirillova I, Chaisson M, Fausto N. Tumor necrosis factor induces DNA replication in hepatic cells through nuclear factor KB activation. Cell Growth Differ 1999; 10: 819828.
  • 30
    Song S, Witek RP, Lu Y, Choi Y-K, Zheng D, Jorgensen M, et al. Ex vivo transduced liver progenitor cells as a platform for gene therapy in mice. HEPATOLOGY 2004; 40: 918924.